Specialty Laboratories (SP) Announces Change In Executive Management; Douglas S. Harrington, M.D., To Step Down As Chief Executive Officer And Director Of Specialty; CEO Search Underway
10/19/2005 5:12:42 PM
VALENCIA, Calif.--(BUSINESS WIRE)--Feb. 14, 2005--Specialty Laboratories, Inc. (Specialty) (NYSE:SP), a leading hospital-focused clinical reference laboratory, announced the departure of Douglas S. Harrington, M.D., as its chief executive officer. Dr. Harrington will remain as Specialty's CEO through March 29, 2005, and will assist the company during the search for his successor. Upon Dr. Harrington's departure, Kevin R. Sayer, Specialty's executive vice president and chief financial officer, will be the company's acting senior officer.
comments powered by